FactoWiki

Evidence review

Bacopa monnieri and memory: human evidence reviewed

Randomised trials of standardised Bacopa monnieri extracts lasting at least 12 weeks suggest small improvements in speed of attention and some memory measures, but results are inconsistent across tests and populations, and at least one trial in healthy adults found no benefit. The effects are modest, slow to appear, and do not show that Bacopa prevents cognitive decline.

Ingredient evidence ≠ product proof

This page reviews research on an ingredient. It does not show that any branded supplement containing that ingredient works, because commercial products may use a different form, dose or combination, and are rarely tested themselves. This is an evidence page: it contains no affiliate links.

The research question

Does taking a standardised Bacopa monnieri extract for several weeks improve memory or cognition in adults?

Evidence table: population → dose → duration → result → limitations

StudyPopulationDose / interventionDurationResultLimitations
Kongkeaw et al., 2014 (meta-analysis)9 RCTs; 518 participants (437 analysed)Standardised extracts, no co-medication≥12 weeksFaster Trail B completion (−17.9 ms) and choice reaction time (−10.6 ms)Most individual memory outcomes not improved; small effects
Pase et al., 2012 (systematic review)Randomised controlled trials in adultsBacopa extractsVariedReported improvements mainly in memory free-recall measuresHeterogeneous tests and extracts
Peth-Nui et al., 201260 healthy older adults (mean age about 63)Standardised extract 300 mg or 600 mg once daily vs placebo12 weeksImproved working-memory measures and faster event-related potential latenciesSmall; single site
Sathyanarayanan et al., 2013Healthy adultsBacopa extract vs placeboSee studyFindings challenged cognitive and anti-anxiety effects in healthy adultsContrasting result; different extract and outcomes

What the results show

The most rigorous pooled analysis (Kongkeaw 2014) included only placebo-controlled trials of standardised extracts lasting 12 weeks or more. It found improvements in two speed-of-processing measures, while most memory outcomes could not be shown to improve. The authors concluded that a large, well-designed trial using a standardised preparation would be needed for definitive answers. A separate systematic review (Pase 2012) emphasised memory free-recall gains, and a later trial in healthy adults (Sathyanarayanan 2013) produced findings that challenged the cognitive-benefit picture. This is a genuine disagreement about how consistent and meaningful the effects are, not a settled positive result.

What the research does not prove

Safety

Limitations of the evidence base

Frequently asked questions

How long does Bacopa take to work in studies?

The pooled trials ran at least 12 weeks; short-term use has not shown the same effects.

Does Bacopa improve memory?

Some measures improved in some trials, but the largest meta-analysis could not show improvement in most memory outcomes; its clearest effect was on speed of attention.

Is Bacopa safe?

It was generally tolerated in trials, with digestive side effects most common; ask a clinician if you take medicines affecting acetylcholine or heart rate.

Related on FactoWiki

Bacopa ingredient guide · What Bacopa does · Brain & memory category

References

  1. Kongkeaw C, Dilokthornsakul P, Thanarangsarit P, Limpeanchob N, Scholfield CN. Meta-analysis of randomized controlled trials on cognitive effects of Bacopa monnieri extract. J Ethnopharmacol. 2014;151(1):528–535. PMID 24252493
  2. Pase MP, et al. The cognitive-enhancing effects of Bacopa monnieri: a systematic review of randomized, controlled human clinical trials. 2012. PMID 22747190
  3. Peth-Nui T, et al. Effects of 12-week Bacopa monnieri consumption on attention, cognitive processing, working memory, and functions of both cholinergic and monoaminergic systems in healthy elderly volunteers. 2012. PMC3537209
  4. Sathyanarayanan V, et al. Brahmi for the better? New findings challenging cognition and anti-anxiety effects of Brahmi (Bacopa monniera) in healthy adults. Psychopharmacology. 2013;227(2):299–306. PMID 23354535
  5. StatPearls: Bacopa monnieri. NBK589635